PAIN TRIGGERS
Standard ADHD medications cause rough side effects like headaches, nausea, or mood changes such as depression.
SaaS· 30-year-old woman with chronic inattentive ADHDPain 7.00/10WTP 6.0/10Market 7.0/10Validation 6.0Confidence 62%May 2, 2026
ADHDsideTrack: Personalized Med Trial Tracker for Inattentive ADHD
Standard ADHD medications deliver inconsistent benefits on focus, motivation, organization and energy while causing severe side effects like headaches, nausea, depression, or risking eating disorder relapse.
ai-poweredchronic-conditiondata-trackinghealthcaremental-healthmobile-appproductivitysaaswellnesswomen-health
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Finding an effective ADHD medication that improves focus, motivation, organization, and energy without causing significant side effects like headaches, nausea, depression, or triggering eating disorder behaviors.
FREQUENCY
Limited repetition signal.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Adhd treatments
ADHD22
Adhd treatments
ADHD22
I’m afraid I'll use those medications to make myself vomit whenever I get upset about my weight.
postAdhd treatments
ADHD22
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
30-year-old woman with chronic inattentive ADHDWomen In Their 30s With Inattentive A D H D
30-year-old women managing chronic inattentive ADHD who cycle through medications seeking better focus and energy without mood crashes, headaches, nausea, or eating disorder triggers.
Context
Identify a sustainable treatment that helps manage inattentive ADHD symptoms while maintaining overall well-being, especially regarding mood and body image/weight concerns.
Trying non-prescribed stimulants for better focus and anxiety reduction.
Current Workarounds
Cycling through prescribed meds like Strattera, Guanfacine, Ritalin, Adderall despite side effects
Trying non-prescribed stimulants for focus and anxiety relief
Using Wellbutrin experimentally while fearing unknown outcomes
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Prescribed medications (Strattera, Guanfacine, Ritalin, Adderall) fail to provide benefits without severe side effects.
Wellbutrin is newly prescribed but uncertain in effectiveness for this user's symptoms.
OPPORTUNITY & VALUE
Why Now
Repeated emphasis on side effect burden from multiple standard meds and fear of eating disorder triggers.
Value Proposition
Hyper-focused on inattentive ADHD in women with built-in safeguards for mood and eating disorder risk tracking, unlike general mood apps or broad ADHD journals.
Product Direction
A mobile/web app for structured daily tracking of symptoms, medication effects, side effects, and mood/weight metrics with AI-generated reports to share with psychiatrists for faster, data-driven med adjustments.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$12/moIndividual user plan with unlimited logs
Model
SaaS subscription
WILLINGNESS TO PAY
Users already invest significant time and emotional energy trialing meds with severe side effects and are actively seeking better solutions; a low monthly fee is far cheaper than repeated ineffective doctor visits or unmanaged symptoms impacting work.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Track your ADHD meds daily and share clean reports with your doctor in one click.”
A mobile/web app for structured daily tracking of symptoms, medication effects, side effects, and mood/weight metrics with AI-generated reports to share with psychiatrists for faster, data-driven med adjustments.
Core Features
Daily symptom + side effect logging with quick presets
Medication timeline with efficacy and side effect scoring
PDF report generator for doctor visits
Mood and appetite/weight correlation charts
Weekly Roadmap
1
W1-W2
Core logging system built and functional for single user testing.
- •Build daily check-in form with ADHD symptom presets
- •Implement medication entry and side effect selector
- •Local data storage and basic timeline view
2
W3-W4
Reporting and visualization complete.
- •Create correlation charts for mood/energy vs meds
- •Build PDF export with timeline summary
- •Add weight/appetite logging module
3
W5
Internal testing and polish with sample ADHD user data.
- •Test flows with 3-5 simulated med trial scenarios
- •Add export sharing options
- •UI polish and onboarding tutorial
4
W6
Beta launch ready with first users.
- •Implement Stripe subscription
- •Deploy to web and iOS/Android test builds
- •Prepare launch post for ADHD communities
Launch Strategy
Launch in r/ADHD, r/ADHDwomen, and ADHD-focused Facebook groups with free trial offers targeting women sharing med trial experiences.
RISKS & ASSUMPTIONS
Top Risks
Medical regulatory risk
Health tracking app could face scrutiny if perceived as giving medical advice; requires strong disclaimers and no diagnostic claims.
User retention during side effects
Users experiencing severe depression or low motivation may stop logging data precisely when insights are most needed.
Data privacy for sensitive health info
Mood, weight, and medication data is highly sensitive; breach could destroy trust in this demographic.
Limited signal validation
Signals center on one detailed user experience; broader market demand for paid tracking tool is unproven.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 6/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "ai-powered", "chronic-condition", "data-tracking", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "ADHDsideTrack: Personalized Med Trial Tracker for Inattentive ADHD" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for ai-powered?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.